Phocas Financial Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-800
Closed -$62.2K 260
2022
Q4
$62.2K Buy
+800
New +$64.8K 0.01% 232
2019
Q2
Hold
0
229
2018
Q4
Hold
0
231
2016
Q2
Sell
-53,330
Closed -$4M 253
2016
Q1
$4M Buy
+53,330
New +$4.02M 0.31% 157
2015
Q4
Sell
-53,947
Closed -$4.06M 146
2015
Q3
$3.61M Sell
53,947
-16,287
-23% -$1.2M 0.31% 156
2015
Q2
$5.2M Sell
70,234
-1,415
-2% -$108K 0.42% 111
2015
Q1
$5.59M Sell
71,649
-10,366
-13% -$786K 0.44% 104
2014
Q4
$5.92M Sell
82,015
-2,525
-3% -$175K 0.52% 88
2014
Q3
$5.24M Sell
84,540
-208
-0.2% -$13.2K 0.47% 101
2014
Q2
$5.4M Sell
84,748
-3,054
-3% -$186K 0.47% 103
2014
Q1
$5.4M Sell
87,802
-1,430
-2% -$83.3K 0.52% 92
2013
Q4
$5.12M Sell
89,232
-11,344
-11% -$643K 0.47% 105
2013
Q3
$5.36M Sell
100,576
-1,662
-2% -$89.4K 0.52% 84
2013
Q2
$5.26M Buy
+102,238
New +$5.05M 0.55% 64

Other funds holding MDT

Phocas Financial Corp's MDT Position: Q1 2023 in Review

Phocas Financial Corp sold out of Medtronic (MDT) in Q1 2023, closing a stake of 800 shares — an estimated $62.2K sold.

Phocas Financial Corp first reported a position in MDT in Q2 2013 and held it in 12 quarters. The position peaked at $5.92M in Q4 2014. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Phocas Financial Corp reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Phocas Financial Corp sold 800 Medtronic shares in Q1 2023, an estimated $62.2K.
  • Phocas Financial Corp first reported a position in Medtronic in Q2 2013 and held it in 12 quarters.
  • Phocas Financial Corp's Medtronic position peaked at $5.92M in Q4 2014.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Phocas Financial Corp's 13F filing for Q1 2023, filed 13 Apr 2023.